3.75
price up icon18.30%   0.58
after-market Dopo l'orario di chiusura: 3.75
loading

Replimune Group Inc Borsa (REPL) Ultime notizie

pulisher
05:33 AM

REPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Lawsuit First Filed by The Rosen Law Firm - The Malaysian Reserve

05:33 AM
pulisher
04:59 AM

Shareholders who lost money on Replimune Group, Inc. - GlobeNewswire

04:59 AM
pulisher
04:57 AM

Shareholders who lost money on Replimune Group, Inc. (NASDAQ: REPL) Should Contact Wolf Haldenstein Immediately as Lead Plaintiff Deadline is September 22nd - GlobeNewswire Inc.

04:57 AM
pulisher
03:19 AM

Replimune (REPL) Faces Securities Class Action Following Stock's Collapse Amid FDA's Rejection of Melanoma DrugHagens Berman - TradingView

03:19 AM
pulisher
03:13 AM

Levi & Korsinsky Notifies Replimune Group, Inc. (REPL) InvestorsLead Plaintiff Deadline on September 22, 2025 - ACCESS Newswire

03:13 AM
pulisher
01:08 AM

Replimune Group (REPL.O) Sees Sharp Intraday Surge — But Why? - AInvest

01:08 AM
pulisher
10:22 AM

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Replimune - Morningstar

10:22 AM
pulisher
07:49 AM

Combining machine learning predictions for Replimune Group Inc.AI Entry Timing Prediction for Swing Traders - Newser

07:49 AM
pulisher
06:22 AM

Market reaction to Replimune Group Inc.’s recent newsFree Stock Market Watch With Alerts - Newser

06:22 AM
pulisher
04:21 AM

How to track smart money flows in Replimune Group Inc.Trend Reversal Probability Forecast Update - Newser

04:21 AM
pulisher
Jul 28, 2025

Investors in Replimune Group, Inc. (REPL) Warned of Potential Securities FraudContact Levi & Korsinsky Today - ACCESS Newswire

Jul 28, 2025
pulisher
Jul 28, 2025

Replimune’s SWOT analysis: biotech stock faces FDA setback, industry remains positive - Investing.com

Jul 28, 2025
pulisher
Jul 28, 2025

Bragar Eagel & Squire, P.C. Reminds Investors of Class - GlobeNewswire

Jul 28, 2025
pulisher
Jul 28, 2025

Replimune (REPL) Faces Securities Class Action Following - GlobeNewswire

Jul 28, 2025
pulisher
Jul 28, 2025

REPL LAWSUIT: Replimune Group, Inc. Sued for Fraud after - GlobeNewswire

Jul 28, 2025
pulisher
Jul 28, 2025

REPL LAWSUIT NOTICE: Replimune Group, Inc. Investors are Notified of the Pending Securities Fraud Class ActionContact BFA Law before the September 22 Deadline - ACCESS Newswire

Jul 28, 2025
pulisher
Jul 28, 2025

REPL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Replimune Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire

Jul 28, 2025
pulisher
Jul 28, 2025

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming Deadlines – REPL - FinancialContent

Jul 28, 2025
pulisher
Jul 28, 2025

Replimune Group, Inc. (REPL) Under Investigation for Potential Securities Law ViolationsContact Levi & Korsinsky Today - ACCESS Newswire

Jul 28, 2025
pulisher
Jul 28, 2025

REPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Barchart.com

Jul 28, 2025
pulisher
Jul 28, 2025

Important Notice to Long-Term Shareholders of Alto - GlobeNewswire

Jul 28, 2025
pulisher
Jul 28, 2025

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire

Jul 28, 2025
pulisher
Jul 28, 2025

REPL Investor Notice: Robbins LLP Reminds Stockholders of the Class Action Lawsuit Against Replimune Group, Inc. - GlobeNewswire

Jul 28, 2025
pulisher
Jul 28, 2025

How to escape a deep drawdown in Replimune Group Inc.Free Growth Based Investment Plan Guidance - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Using portfolio simulators with Replimune Group Inc. includedFree Buy Low Sell High Stock Watch - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Order flow analysis tools used on Replimune Group Inc. Buy/Sell Zone Confirmation Technical Analysis - Newser

Jul 28, 2025
pulisher
Jul 27, 2025

Securities Litigation in Biotech: Navigating the Replimune Crisis and Its Broader Implications - AInvest

Jul 27, 2025
pulisher
Jul 27, 2025

Regulatory Setbacks and Legal Risks: Replimune Group's Turbulent Path in the Biotech Sector - AInvest

Jul 27, 2025
pulisher
Jul 27, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Replimune Group, Inc.REPL - WV News

Jul 27, 2025
pulisher
Jul 27, 2025

Leerink Partnrs Expects Lower Earnings for Replimune Group - Defense World

Jul 27, 2025
pulisher
Jul 26, 2025

REPL CLASS ACTION ALERT: FDA Response Letter Leads to - GlobeNewswire

Jul 26, 2025
pulisher
Jul 26, 2025

Replimune Group (NASDAQ:REPL) Cut to “Underperform” at BMO Capital Markets - Defense World

Jul 26, 2025
pulisher
Jul 26, 2025

Replimune Group (NASDAQ:REPL) Cut to “Equal Weight” at Barclays - Defense World

Jul 26, 2025
pulisher
Jul 26, 2025

Replimune Group (NASDAQ:REPL) Cut to “Neutral” at HC Wainwright - Defense World

Jul 26, 2025
pulisher
Jul 25, 2025

REPLIMUNE GROUP, INC. (NASDAQ: REPL) INVESTOR ALERT Investors With Large Losses in Replimune Group, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights - ACCESS Newswire

Jul 25, 2025
pulisher
Jul 25, 2025

[REPL] ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Replimune Group, Inc. Investors - TradingView

Jul 25, 2025
pulisher
Jul 25, 2025

Potential Securities Fraud: Levi & Korsinsky Investigates Replimune Group, Inc. (REPL) - ACCESS Newswire

Jul 25, 2025
pulisher
Jul 25, 2025

Replimune Group, Inc. Investors: Company Investigated by the Portnoy Law Firm - GlobeNewswire

Jul 25, 2025
pulisher
Jul 25, 2025

Lost Money on Replimune Group, Inc. (REPL)? Possible FraudContact Levi & Korsinsky Today - ACCESS Newswire

Jul 25, 2025
pulisher
Jul 25, 2025

Is Replimune Group Inc. a good long term investmentTremendous wealth creation - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

ROSEN, LEADING INVESTOR COUNSEL, Encourages Replimune - GlobeNewswire

Jul 25, 2025
pulisher
Jul 25, 2025

REPL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

Jul 25, 2025
pulisher
Jul 25, 2025

Ongoing Replimune Group, Inc. (REPL) Investigation: Protect Your RightsContact Levi & Korsinsky - ACCESS Newswire

Jul 25, 2025
pulisher
Jul 25, 2025

Faruqi & Faruqi Reminds Replimune Investors of the Pending - GlobeNewswire

Jul 25, 2025
pulisher
Jul 25, 2025

REPL LEGAL UPDATE: Replimune Group, Inc. Sued after FDA Response Letter -- Investors with Losses are Notified to Contact BFA Law before September 22 Class Action Deadline - FinancialContent

Jul 25, 2025
pulisher
Jul 25, 2025

INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of - GlobeNewswire

Jul 25, 2025
pulisher
Jul 25, 2025

Faruqi & Faruqi Reminds Replimune Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025 – REPL - Morningstar

Jul 25, 2025
pulisher
Jul 25, 2025

REPL INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP - GlobeNewswire

Jul 25, 2025
pulisher
Jul 25, 2025

Replimune Group (NASDAQ:REPL) Cut to “Hold” at Leerink Partnrs - Defense World

Jul 25, 2025
pulisher
Jul 25, 2025

Replimune Group (NASDAQ:REPL) Cut to Hold at Cantor Fitzgerald - Defense World

Jul 25, 2025
pulisher
Jul 25, 2025

Shareholder Alert: Robbins LLP Informs Investors of The Replimune Group, Inc. Class Action - ACCESS Newswire

Jul 25, 2025
pulisher
Jul 24, 2025

Replimune Group and the Biotech Litigation Time Bomb: Evaluating Risks in a High-Stakes Sector - AInvest

Jul 24, 2025
pulisher
Jul 24, 2025

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of Replimune Group, Inc. Investors – REPL - Business Wire

Jul 24, 2025
pulisher
Jul 24, 2025

Shareholders Alert: Investigation Into Replimune Group, Inc. (REPL)Contact Levi & Korsinsky to Protect Your Rights - ACCESS Newswire

Jul 24, 2025
pulisher
Jul 24, 2025

INVESTOR ALERT: Investigation of Replimune Group, Inc. (REPL) Announced by Holzer & Holzer, LLC - GlobeNewswire

Jul 24, 2025
pulisher
Jul 24, 2025

REPL STOCK NEWS: Replimune Group, Inc. (NASDAQ:REPL) is - GlobeNewswire

Jul 24, 2025
pulisher
Jul 24, 2025

REPL ACTIVE INVESTIGATION: Lost Money on Replimune Group, Inc.? Contact Levi & Korsinsky Now - ACCESS Newswire

Jul 24, 2025
$77.38
price up icon 10.28%
$37.27
price up icon 0.57%
$105.00
price up icon 3.19%
$26.74
price down icon 2.59%
$111.48
price down icon 1.16%
biotechnology ONC
$305.74
price up icon 3.81%
Capitalizzazione:     |  Volume (24 ore):